Free Trial

Baker Hughes (BKR) Financials

Baker Hughes logo
$44.76 +1.30 (+2.99%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$44.56 -0.20 (-0.44%)
As of 07:10 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Baker Hughes

Annual Income Statements for Baker Hughes

This table shows Baker Hughes' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
0.00 0.00 -103 195 128 -9,940 -219 -601 1,943 2,979
Consolidated Net Income / (Loss)
-631 185 -391 283 271 -15,761 -330 -578 1,970 3,008
Net Income / (Loss) Continuing Operations
-631 185 -391 283 271 -15,761 -330 -578 1,970 3,008
Total Pre-Tax Income
-158 358 -335 680 753 -15,202 428 22 2,655 3,265
Total Operating Income
-138 457 -284 701 1,074 -15,978 1,310 1,185 2,317 3,081
Total Gross Profit
4,495 2,932 3,036 3,986 4,432 3,199 4,049 4,400 5,251 5,840
Total Revenue
16,688 13,082 17,179 22,877 23,838 20,705 20,502 21,156 25,506 27,829
Total Cost of Revenue
12,193 10,150 14,143 18,891 19,406 17,506 16,453 16,756 20,255 21,989
Operating Cost of Revenue
12,193 10,150 14,143 18,891 19,406 17,506 16,453 16,756 20,255 21,989
Total Operating Expenses
4,633 2,475 3,320 3,285 3,358 19,043 2,739 3,215 2,934 2,759
Selling, General & Admin Expense
2,115 1,926 2,535 2,699 2,832 2,404 2,470 2,510 2,611 2,458
Impairment Charge
2,080 - - 0.00 342 14,773 269 705 323 301
Total Other Income / (Expense), net
-20 -99 -51 -21 -321 776 -882 -1,163 338 184
Interest Expense
120 102 131 223 237 264 299 252 216 198
Other Income / (Expense), net
100 3.00 80 202 -84 1,040 -583 -911 554 382
Income Tax Expense
473 173 45 258 482 559 758 600 685 257
Net Income / (Loss) Attributable to Noncontrolling Interest
-25 -69 -330 88 143 -5,821 -111 23 27 29
Basic Earnings per Share
$0.00 $0.00 ($0.24) $0.46 $0.23 $0.00 ($0.27) ($0.61) $1.93 $3.00
Weighted Average Basic Shares Outstanding
- - 1.47B 427M 1.03B 1.04B 2.05B 1.01B 1.00B 990.11M
Diluted Earnings per Share
$0.00 $0.00 ($0.24) $0.45 $0.23 ($14.73) ($0.27) ($0.61) $1.91 $2.98
Weighted Average Diluted Shares Outstanding
- - 1.47B 427M 1.03B 1.04B 2.05B 1.01B 1.00B 990.11M
Weighted Average Basic & Diluted Shares Outstanding
- - 1.47B 427M 1.03B 1.04B 2.05B 1.01B 1.00B 990.11M
Cash Dividends to Common per Share
$0.00 - - $0.00 $0.72 $0.00 $0.72 $0.73 $0.78 $0.84

Quarterly Income Statements for Baker Hughes

This table shows Baker Hughes' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
183 576 410 518 439 455 579 766 1,179 402 701
Consolidated Net Income / (Loss)
188 581 414 524 451 463 581 774 1,190 409 711
Net Income / (Loss) Continuing Operations
188 581 414 524 451 419 581 774 1,190 409 711
Total Pre-Tax Income
346 760 614 759 522 641 824 1,009 791 561 967
Total Operating Income
662 438 514 714 651 660 845 930 665 752 887
Total Gross Profit
1,336 1,149 1,311 1,343 1,448 1,442 1,646 1,542 1,530 1,475 1,615
Total Revenue
5,905 5,716 6,315 6,641 6,834 6,418 7,139 6,908 7,364 6,427 6,910
Total Cost of Revenue
4,569 4,567 5,004 5,298 5,386 4,976 5,493 5,366 5,834 4,952 5,295
Operating Cost of Revenue
4,569 4,567 5,004 5,298 5,386 4,976 5,493 5,366 5,834 4,952 5,295
Total Operating Expenses
674 711 797 629 797 782 801 612 865 723 728
Selling, General & Admin Expense
645 655 695 627 634 618 643 612 585 577 567
Research & Development Expense
- - - - - 164 158 - - 146 161
Total Other Income / (Expense), net
-316 322 100 45 -129 -63 -21 79 126 -191 80
Interest Expense
63 64 58 49 45 41 47 55 55 51 54
Other Income / (Expense), net
-253 386 158 94 -84 -22 26 134 181 -140 134
Income Tax Expense
158 179 200 235 71 178 243 235 -399 152 256
Net Income / (Loss) Attributable to Noncontrolling Interest
5.00 5.00 4.00 6.00 12 8.00 2.00 8.00 11 7.00 10
Basic Earnings per Share
$0.25 $0.57 $0.41 $0.51 $0.44 $0.46 $0.58 $0.77 $1.19 $0.41 $0.71
Weighted Average Basic Shares Outstanding
1.01B 1.01B 1.01B 1.01B 1.00B 998.00M 993.42M 989.53M 990.11M 990.75M 985.88M
Diluted Earnings per Share
$0.25 $0.57 $0.40 $0.51 $0.43 $0.45 $0.58 $0.77 $1.18 $0.40 $0.71
Weighted Average Diluted Shares Outstanding
1.01B 1.01B 1.01B 1.01B 1.00B 998.00M 993.42M 989.53M 990.11M 990.75M 985.88M
Weighted Average Basic & Diluted Shares Outstanding
1.01B 1.01B 1.01B 1.01B 1.00B 998.00M 993.42M 989.53M 990.11M 990.75M 985.88M
Cash Dividends to Common per Share
$0.37 $0.19 $0.19 $0.20 $0.20 $0.21 $0.21 $0.21 $0.21 $0.23 $0.23

Annual Cash Flow Statements for Baker Hughes

This table details how cash moves in and out of Baker Hughes' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
42 -451 5,997 -3,307 -474 883 -279 -1,365 158 718
Net Cash From Operating Activities
1,277 262 -799 1,762 2,126 1,304 2,374 1,888 3,062 3,332
Net Cash From Continuing Operating Activities
1,277 262 -799 1,762 2,126 1,304 2,374 1,888 3,062 3,332
Net Income / (Loss) Continuing Operations
-631 185 -391 283 271 -15,761 -330 -578 1,970 3,008
Consolidated Net Income / (Loss)
-631 185 -391 283 271 -15,761 -330 -578 1,970 3,008
Depreciation Expense
530 550 1,103 1,486 1,418 1,317 1,105 1,061 1,087 1,136
Non-Cash Adjustments To Reconcile Net Income
2,080 0.00 11 153 245 15,355 1,057 1,089 -399 -88
Changes in Operating Assets and Liabilities, net
-702 -473 -1,522 -160 192 393 542 316 404 -724
Net Cash From Investing Activities
-466 -472 -4,123 -578 -1,045 -618 -463 -1,564 -817 -1,016
Net Cash From Continuing Investing Activities
-466 -472 -4,123 -578 -1,045 -618 -463 -1,564 -817 -1,016
Purchase of Property, Plant & Equipment
-607 -424 -665 -995 -1,240 -974 -856 -989 -1,224 -1,278
Acquisitions
-86 -16 -3,375 -530 -176 -57 -87 -767 -301 0.00
Sale of Property, Plant & Equipment
30 20 172 458 264 187 315 217 208 203
Divestitures
181 0.00 20 453 77 187 70 0.00 293 0.00
Sale and/or Maturity of Investments
- - - - - - 147 26 372 92
Other Investing Activities, net
16 -52 -275 36 30 39 -52 -51 -165 -33
Net Cash From Financing Activities
-515 -102 10,919 -4,363 -1,534 225 -2,143 -1,592 -2,028 -1,527
Net Cash From Continuing Financing Activities
-515 -102 10,919 -4,363 -1,534 225 -2,143 -1,592 -2,028 -1,527
Repayment of Debt
193 -293 -1,024 -1,067 -1,064 469 -2,210 -38 -704 -207
Repurchase of Common Equity
0.00 0.00 -477 -2,486 -250 0.00 -434 -828 -538 -484
Payment of Dividends
0.00 0.00 -406 -810 -745 -744 -749 -726 -786 -836
Effect of Exchange Rate Changes
-254 -139 - -128 -21 -28 -47 -97 -59 -71
Cash Interest Paid
52 55 109 - - - - 291 309 298
Cash Income Taxes Paid
264 317 230 - - - - 498 595 1,040

Quarterly Cash Flow Statements for Baker Hughes

This table details how cash moves in and out of Baker Hughes' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents
-363 -73 390 396 -555 71 -433 380 700 -87 -190
Net Cash From Operating Activities
898 461 859 810 932 784 348 1,010 1,190 709 510
Net Cash From Continuing Operating Activities
898 461 859 810 932 784 348 1,010 1,190 709 510
Net Income / (Loss) Continuing Operations
188 581 414 524 451 463 581 773 1,191 409 711
Consolidated Net Income / (Loss)
188 581 414 524 451 463 581 773 1,191 409 711
Depreciation Expense
255 269 276 268 274 283 283 278 292 285 294
Non-Cash Adjustments To Reconcile Net Income
145 -325 -84 -39 49 -1.00 31 -47 -71 190 -67
Changes in Operating Assets and Liabilities, net
310 -64 253 57 158 39 -547 6.00 -222 -175 -428
Net Cash From Investing Activities
-984 -229 -185 -89 -314 -269 -261 -269 -217 -310 -286
Net Cash From Continuing Investing Activities
-984 -229 -185 -89 -314 -269 -261 -269 -217 -310 -286
Purchase of Property, Plant & Equipment
-269 -310 -277 -281 -356 -333 -292 -300 -353 -300 -301
Sale of Property, Plant & Equipment
28 46 41 63 58 51 50 44 58 45 29
Other Investing Activities, net
-62 35 40 -224 -16 13 -19 -34 7.00 -55 -14
Net Cash From Financing Activities
-295 -250 -300 -311 -1,167 -427 -502 -364 -234 -502 -443
Net Cash From Continuing Financing Activities
-295 -250 -300 -311 -1,167 -427 -502 -364 -234 -502 -443
Repayment of Debt
-4.00 -58 -9.00 11 -648 -59 -127 -3.00 -18 -85 -20
Repurchase of Common Equity
-101 0.00 -99 -120 -319 -158 -166 -152 -8.00 -188 -196
Payment of Dividends
-190 -192 -192 -202 -200 -210 -209 -209 -208 -229 -227
Effect of Exchange Rate Changes
18 -55 16 -14 -6.00 -17 -18 3.00 -39 16 29
Cash Interest Paid
101 50 107 48 104 48 102 49 99 50 98
Cash Income Taxes Paid
103 163 160 140 132 108 228 397 307 207 211

Annual Balance Sheets for Baker Hughes

This table presents Baker Hughes' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
21,721 56,500 52,439 53,369 38,007 35,308 34,181 36,945 38,363
Total Current Assets
7,401 18,424 14,971 15,222 16,455 15,065 14,592 16,301 17,211
Cash & Equivalents
981 - - - 4,132 - 2,488 2,646 3,364
Accounts Receivable
2,563 6,015 5,969 6,416 5,622 5,651 5,958 7,075 7,122
Inventories, net
3,224 4,507 4,620 4,608 4,421 3,979 4,587 5,094 4,954
Other Current Assets
633 872 659 949 2,280 1,582 1,559 1,486 1,771
Plant, Property, & Equipment, net
2,325 6,959 6,228 6,240 5,358 4,877 4,538 4,893 5,127
Total Noncurrent Assets
11,995 31,117 31,240 31,907 16,194 15,366 15,051 15,751 16,025
Goodwill
6,680 19,927 20,717 20,690 5,977 5,959 5,930 6,137 6,078
Intangible Assets
2,449 6,358 5,719 5,381 4,397 4,131 4,180 4,093 3,951
Noncurrent Deferred & Refundable Income Taxes
326 715 1,072 954 953 735 657 722 1,284
Other Noncurrent Operating Assets
2,540 4,117 3,732 4,882 4,867 4,541 4,284 4,799 4,712
Total Liabilities & Shareholders' Equity
21,721 56,500 52,439 53,369 38,007 35,308 34,181 36,945 38,363
Total Liabilities
6,866 18,090 17,426 18,870 19,765 18,562 19,656 21,426 21,308
Total Current Liabilities
4,934 9,227 9,020 10,014 10,227 9,128 11,075 12,991 12,991
Short-Term Debt
239 2,037 942 321 889 40 677 148 53
Accounts Payable
1,898 3,377 4,025 4,268 3,532 3,745 4,298 4,471 4,542
Current Deferred Revenue
1,596 1,775 1,765 2,870 3,454 3,232 3,822 5,542 5,672
Other Current Liabilities
1,201 2,038 2,288 2,555 2,352 2,111 2,278 2,830 2,724
Total Noncurrent Liabilities
1,932 8,863 8,406 8,856 9,538 9,434 8,581 8,435 8,317
Long-Term Debt
38 6,312 6,285 6,301 6,744 6,687 5,980 5,872 5,970
Noncurrent Deferred & Payable Income Tax Liabilities
880 490 143 51 186 127 229 176 83
Noncurrent Employee Benefit Liabilities
519 1,172 1,018 1,079 1,217 1,110 960 978 988
Other Noncurrent Operating Liabilities
495 889 960 1,425 1,391 1,510 1,412 1,409 1,276
Total Equity & Noncontrolling Interests
14,855 38,410 35,013 34,499 18,242 16,746 14,525 15,519 17,055
Total Preferred & Common Equity
14,688 14,277 17,465 21,929 12,893 14,830 14,394 15,368 16,895
Total Common Equity
14,688 14,277 17,465 21,929 12,893 14,830 14,394 15,368 16,895
Common Stock
0.00 15,083 18,659 23,565 24,613 27,375 28,126 26,983 25,896
Retained Earnings
0.00 -103 25 0.00 -9,942 -10,160 -10,761 -8,819 -5,840
Accumulated Other Comprehensive Income / (Loss)
-1,894 -703 -1,219 -1,636 -1,778 -2,385 -2,971 -2,796 -3,161
Noncontrolling Interest
167 24,133 17,548 12,570 5,349 1,916 131 151 160

Quarterly Balance Sheets for Baker Hughes

This table presents Baker Hughes' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Total Assets
34,181 35,042 36,093 36,550 36,945 37,141 36,656 37,530 38,363 38,110 38,740
Total Current Assets
14,592 15,386 15,806 16,161 16,301 16,420 15,930 16,568 17,211 16,841 17,618
Cash & Equivalents
2,488 2,415 2,805 3,201 2,646 2,717 2,284 2,664 3,364 3,277 3,087
Accounts Receivable
5,958 6,291 6,418 6,505 7,075 6,873 7,051 6,920 7,122 6,710 6,511
Inventories, net
4,587 4,786 4,957 4,964 5,094 5,339 5,126 5,254 4,954 5,161 5,105
Other Current Assets
1,559 1,894 1,626 1,491 1,486 1,491 1,469 1,730 1,771 1,693 2,915
Plant, Property, & Equipment, net
4,538 4,513 4,723 4,768 4,893 4,931 4,951 5,150 5,127 5,168 5,176
Total Noncurrent Assets
15,051 15,143 15,564 15,621 15,751 15,790 15,775 15,812 16,025 16,101 15,946
Goodwill
5,930 5,916 6,074 6,048 6,137 6,114 6,105 6,167 6,078 6,126 5,801
Intangible Assets
4,180 4,123 4,124 4,104 4,093 4,055 4,019 3,995 3,951 3,927 3,919
Noncurrent Deferred & Refundable Income Taxes
657 663 670 687 722 730 676 649 1,284 1,363 1,371
Other Noncurrent Operating Assets
4,284 4,441 4,696 4,782 4,799 4,891 4,975 5,001 4,712 4,685 4,855
Total Liabilities & Shareholders' Equity
34,181 35,042 36,093 36,550 36,945 37,141 36,656 37,530 38,363 38,110 38,740
Total Liabilities
19,656 20,193 20,831 21,155 21,426 21,591 20,935 21,187 21,308 20,904 20,872
Total Current Liabilities
11,075 11,618 12,311 12,681 12,991 13,179 12,586 12,790 12,991 12,594 12,515
Short-Term Debt
677 684 797 802 148 147 34 52 53 55 66
Accounts Payable
4,298 4,263 4,154 4,123 4,471 4,595 4,649 4,431 4,542 4,465 4,340
Current Deferred Revenue
3,822 4,434 5,101 5,187 5,542 5,711 5,506 5,685 5,672 5,589 5,680
Other Current Liabilities
2,278 2,237 2,259 2,569 2,830 2,726 2,397 2,622 2,724 2,485 2,429
Total Noncurrent Liabilities
8,581 8,575 8,520 8,474 8,435 8,412 8,349 8,397 8,317 8,310 8,357
Long-Term Debt
5,980 5,975 5,847 5,857 5,872 5,859 5,861 5,984 5,970 5,969 5,968
Noncurrent Deferred & Payable Income Tax Liabilities
229 246 283 280 176 149 156 154 83 93 106
Noncurrent Employee Benefit Liabilities
960 932 968 952 978 984 984 991 988 985 997
Other Noncurrent Operating Liabilities
1,412 1,422 1,422 1,385 1,409 1,420 1,348 1,268 1,276 1,263 1,286
Total Equity & Noncontrolling Interests
14,525 14,849 15,262 15,395 15,519 15,550 15,721 16,343 17,055 17,206 17,868
Total Preferred & Common Equity
14,394 14,714 15,125 15,250 15,368 15,391 15,574 16,189 16,895 17,042 17,697
Total Common Equity
14,394 14,714 15,125 15,250 15,368 15,391 15,574 16,189 16,895 17,042 17,697
Common Stock
28,126 27,925 27,696 27,415 26,983 26,610 26,340 26,045 25,896 25,450 25,087
Retained Earnings
-10,761 -10,185 -9,776 -9,258 -8,819 -8,364 -7,785 -7,019 -5,840 -5,438 -4,737
Accumulated Other Comprehensive Income / (Loss)
-2,971 -3,026 -2,795 -2,907 -2,796 -2,855 -2,981 -2,837 -3,161 -2,970 -2,653
Noncontrolling Interest
131 135 137 145 151 159 147 154 160 164 171

Annual Metrics And Ratios for Baker Hughes

This table displays calculated financial ratios and metrics derived from Baker Hughes' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% -21.61% 31.32% 33.17% 4.20% -13.14% -0.98% 3.19% 20.56% 9.11%
EBITDA Growth
0.00% 105.28% -10.99% 165.74% 0.80% -665.66% 113.45% -27.13% 196.48% 16.20%
EBIT Growth
0.00% 1,310.53% -144.35% 542.65% 9.63% -1,608.89% 104.87% -62.31% 947.81% 20.62%
NOPAT Growth
0.00% 344.47% -184.18% 318.83% -11.15% -2,993.62% 90.97% -2,982.35% 105.52% 65.10%
Net Income Growth
0.00% 129.32% -311.35% 172.38% -4.24% -5,915.87% 97.91% -75.15% 440.83% 52.69%
EPS Growth
0.00% 0.00% 0.00% 287.50% -48.89% -6,504.35% 98.17% -125.93% 413.11% 56.02%
Operating Cash Flow Growth
0.00% -79.48% -404.96% 320.53% 20.66% -38.66% 82.06% -20.47% 62.18% 8.82%
Free Cash Flow Firm Growth
0.00% 0.00% -85.25% 106.39% -37.37% 379.33% -77.49% -2,814.15% 105.03% 32.71%
Invested Capital Growth
0.00% 0.00% 180.75% -3.05% -1.67% -42.59% -9.76% -4.72% 1.06% 4.35%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 2.08% 0.35% -3.95% -0.05% 2.03% 3.78% 1.94%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 32.94% -6.34% 7.94% -31.49% -22.65% 4.68% 6.90%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 225.99% -14.14% 7.55% -52.64% -57.65% 5.82% 8.76%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 213.73% -34.07% -0.93% -586.05% -2,309.02% 7.25% 22.20%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 385.86% -43.42% 5.16% -215.79% -34.42% 15.41% 32.57%
EPS Q/Q Growth
0.00% 0.00% 0.00% 104.55% -48.89% 8.68% -133.75% -35.56% 10.40% 33.63%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -524.22% 283.88% 14.42% -42.91% 20.08% 7.03% 1.12% 8.39%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -1.03% -25.95% -8.08% -7,456.05% 65.06% 38.11%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -1.47% -1.97% 4.15% -1.28% 2.88% 0.21% -0.01%
Profitability Metrics
- - - - - - - - - -
Gross Margin
26.94% 22.41% 17.67% 17.42% 18.59% 15.45% 19.75% 20.80% 20.59% 20.99%
EBITDA Margin
2.95% 7.72% 5.23% 10.44% 10.10% -65.79% 8.94% 6.31% 15.52% 16.53%
Operating Margin
-0.83% 3.49% -1.65% 3.06% 4.51% -77.17% 6.39% 5.60% 9.08% 11.07%
EBIT Margin
-0.23% 3.52% -1.19% 3.95% 4.15% -72.15% 3.55% 1.30% 11.26% 12.44%
Profit (Net Income) Margin
-3.78% 1.41% -2.28% 1.24% 1.14% -76.12% -1.61% -2.73% 7.72% 10.81%
Tax Burden Percent
399.37% 51.68% 116.72% 41.62% 35.99% 103.68% -77.10% -2,627.27% 74.20% 92.13%
Interest Burden Percent
415.79% 77.83% 164.22% 75.30% 76.06% 101.77% 58.87% 8.03% 92.48% 94.28%
Effective Tax Rate
0.00% 48.32% 0.00% 37.94% 64.01% 0.00% 177.10% 2,727.27% 25.80% 7.87%
Return on Invested Capital (ROIC)
0.00% 3.34% -0.74% 1.11% 1.01% -37.52% -4.88% -162.52% 9.15% 14.70%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 17.87% -63.24% -5.19% -2.35% -170.67% 16.45% 705.16% 15.80% 20.32%
Return on Net Nonoperating Assets (RNNOA)
0.00% -0.85% -0.73% -0.34% -0.23% -22.24% 3.00% 158.82% 3.97% 3.76%
Return on Equity (ROE)
0.00% 2.49% -1.47% 0.77% 0.78% -59.77% -1.89% -3.70% 13.11% 18.47%
Cash Return on Invested Capital (CROIC)
0.00% -196.66% -95.68% 4.21% 2.70% 16.59% 5.38% -157.68% 8.09% 10.45%
Operating Return on Assets (OROA)
0.00% 2.12% -0.52% 1.66% 1.87% -32.70% 1.98% 0.79% 8.07% 9.20%
Return on Assets (ROA)
0.00% 0.85% -1.00% 0.52% 0.51% -34.50% -0.90% -1.66% 5.54% 7.99%
Return on Common Equity (ROCE)
0.00% 2.46% -0.80% 0.33% 0.44% -39.46% -1.49% -3.45% 12.99% 18.29%
Return on Equity Simple (ROE_SIMPLE)
0.00% 1.26% -2.74% 1.62% 1.24% -122.24% -2.23% -4.02% 12.82% 17.80%
Net Operating Profit after Tax (NOPAT)
-97 236 -199 435 387 -11,185 -1,010 -31,133 1,719 2,838
NOPAT Margin
-0.58% 1.81% -1.16% 1.90% 1.62% -54.02% -4.93% -147.16% 6.74% 10.20%
Net Nonoperating Expense Percent (NNEP)
0.00% -14.53% 62.50% 6.30% 3.36% 133.15% -21.33% -867.68% -6.65% -5.62%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -146.98% 7.98% 12.30%
Cost of Revenue to Revenue
73.06% 77.59% 82.33% 82.58% 81.41% 84.55% 80.25% 79.20% 79.41% 79.01%
SG&A Expenses to Revenue
12.67% 14.72% 14.76% 11.80% 11.88% 11.61% 12.05% 11.86% 10.24% 8.83%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
27.76% 18.92% 19.33% 14.36% 14.09% 91.97% 13.36% 15.20% 11.50% 9.91%
Earnings before Interest and Taxes (EBIT)
-38 460 -204 903 990 -14,938 727 274 2,871 3,463
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
492 1,010 899 2,389 2,408 -13,621 1,832 1,335 3,958 4,599
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 2.11 1.15 1.05 1.53 1.59 1.97 2.18 2.40
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 7.84 4.97 6.61 6.53 5.91
Price to Revenue (P/Rev)
0.00 0.00 1.75 0.88 0.97 0.95 1.15 1.34 1.31 1.46
Price to Earnings (P/E)
0.00 0.00 0.00 103.14 180.53 0.00 0.00 0.00 17.26 13.63
Dividend Yield
0.00% 0.00% 67.92% 3.94% 4.00% 3.77% 3.17% 2.60% 2.34% 2.05%
Earnings Yield
0.00% 0.00% 0.00% 0.97% 0.55% 0.00% 0.00% 0.00% 5.80% 7.34%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.40 1.07 1.03 1.32 1.44 1.75 1.96 2.20
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 3.23 1.80 1.64 1.38 1.38 1.54 1.45 1.56
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 61.79 17.23 16.22 0.00 15.47 24.45 9.36 9.44
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 45.59 39.45 0.00 38.98 119.11 12.91 12.54
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 94.63 101.03 0.00 0.00 0.00 21.55 15.29
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 23.36 18.37 21.94 11.94 17.29 12.10 13.03
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 24.99 37.86 5.79 25.46 0.00 24.37 21.52
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.02 0.22 0.21 0.19 0.42 0.40 0.46 0.39 0.35
Long-Term Debt to Equity
0.00 0.00 0.16 0.18 0.18 0.37 0.40 0.41 0.38 0.35
Financial Leverage
0.00 -0.05 0.01 0.07 0.10 0.13 0.18 0.23 0.25 0.19
Leverage Ratio
0.00 1.46 1.47 1.48 1.52 1.73 2.10 2.22 2.37 2.31
Compound Leverage Factor
0.00 1.14 2.41 1.12 1.16 1.76 1.23 0.18 2.19 2.18
Debt to Total Capital
0.00% 1.83% 17.86% 17.11% 16.10% 29.50% 28.66% 31.43% 27.95% 26.10%
Short-Term Debt to Total Capital
0.00% 1.58% 4.36% 2.23% 0.78% 3.44% 0.17% 3.20% 0.69% 0.23%
Long-Term Debt to Total Capital
0.00% 0.25% 13.50% 14.88% 15.32% 26.06% 28.49% 28.23% 27.26% 25.87%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 1.10% 51.61% 41.54% 30.57% 20.67% 8.16% 0.62% 0.70% 0.69%
Common Equity to Total Capital
0.00% 97.07% 30.53% 41.35% 53.33% 49.83% 63.18% 67.95% 71.35% 73.21%
Debt to EBITDA
0.00 0.27 9.29 3.03 2.75 -0.56 3.67 4.99 1.52 1.31
Net Debt to EBITDA
0.00 -0.70 1.47 1.47 1.40 -0.26 1.57 3.12 0.85 0.58
Long-Term Debt to EBITDA
0.00 0.04 7.02 2.63 2.62 -0.50 3.65 4.48 1.48 1.30
Debt to NOPAT
0.00 1.17 -42.00 16.61 17.13 -0.68 -6.66 -0.21 3.50 2.12
Net Debt to NOPAT
0.00 -2.98 -6.63 8.05 8.73 -0.31 -2.85 -0.13 1.96 0.94
Long-Term Debt to NOPAT
0.00 0.16 -31.75 14.45 16.30 -0.60 -6.62 -0.19 3.42 2.10
Altman Z-Score
0.00 0.00 1.48 1.32 1.36 -0.32 1.21 1.19 1.66 2.09
Noncontrolling Interest Sharing Ratio
0.00% 1.12% 45.62% 56.77% 43.33% 33.98% 20.76% 6.55% 0.94% 0.95%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.00 1.50 2.00 1.66 1.52 1.61 1.65 1.32 1.25 1.32
Quick Ratio
0.00 0.72 0.65 0.66 0.64 0.95 0.62 0.76 0.75 0.81
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -13,915 -25,777 1,647 1,032 4,944 1,113 -30,207 1,520 2,017
Operating Cash Flow to CapEx
221.32% 64.85% -162.07% 328.12% 217.83% 165.69% 438.82% 244.56% 301.38% 309.95%
Free Cash Flow to Firm to Interest Expense
0.00 -136.42 -196.77 7.39 4.35 18.73 3.72 -119.87 7.04 10.19
Operating Cash Flow to Interest Expense
10.64 2.57 -6.10 7.90 8.97 4.94 7.94 7.49 14.18 16.83
Operating Cash Flow Less CapEx to Interest Expense
5.83 -1.39 -9.86 5.49 4.85 1.96 6.13 4.43 9.47 11.40
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.60 0.44 0.42 0.45 0.45 0.56 0.61 0.72 0.74
Accounts Receivable Turnover
0.00 5.10 4.01 3.82 3.85 3.44 3.64 3.64 3.91 3.92
Inventory Turnover
0.00 3.15 3.66 4.14 4.21 3.88 3.92 3.91 4.18 4.38
Fixed Asset Turnover
0.00 5.63 3.70 3.47 3.82 3.57 4.01 4.49 5.41 5.55
Accounts Payable Turnover
0.00 5.35 5.36 5.10 4.68 4.49 4.52 4.17 4.62 4.88
Days Sales Outstanding (DSO)
0.00 71.51 91.13 95.60 94.82 106.11 100.35 100.14 93.25 93.10
Days Inventory Outstanding (DIO)
0.00 115.94 99.76 88.17 86.78 94.13 93.17 93.30 87.23 83.39
Days Payable Outstanding (DPO)
0.00 68.25 68.07 71.51 77.99 81.32 80.72 87.60 79.01 74.80
Cash Conversion Cycle (CCC)
0.00 119.19 122.82 112.27 103.61 118.92 112.80 105.84 101.47 101.69
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
0.00 14,151 39,729 38,517 37,872 21,743 19,620 18,694 18,893 19,714
Invested Capital Turnover
0.00 1.85 0.64 0.58 0.62 0.69 0.99 1.10 1.36 1.44
Increase / (Decrease) in Invested Capital
0.00 14,151 25,578 -1,212 -645 -16,129 -2,123 -926 199 821
Enterprise Value (EV)
0.00 0.00 55,553 41,165 39,051 28,609 28,340 32,636 37,052 43,409
Market Capitalization
0.00 0.00 30,101 20,113 23,108 19,759 23,550 28,336 33,527 40,590
Book Value per Share
$0.00 $0.00 $12.47 $15.88 $21.35 $12.45 $14.31 $14.27 $15.27 $17.07
Tangible Book Value per Share
$0.00 $0.00 ($10.48) ($8.16) ($4.03) $2.43 $4.57 $4.25 $5.11 $6.94
Total Capital
0.00 15,132 46,759 42,240 41,121 25,875 23,473 21,182 21,539 23,078
Total Debt
0.00 277 8,349 7,227 6,622 7,633 6,727 6,657 6,020 6,023
Total Long-Term Debt
0.00 38 6,312 6,285 6,301 6,744 6,687 5,980 5,872 5,970
Net Debt
0.00 -704 1,319 3,504 3,373 3,501 2,874 4,169 3,374 2,659
Capital Expenditures (CapEx)
577 404 493 537 976 787 541 772 1,016 1,075
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 1,725 4,204 3,170 2,280 2,985 2,124 1,706 812 909
Debt-free Net Working Capital (DFNWC)
0.00 2,706 11,234 6,893 5,529 7,117 5,977 4,194 3,458 4,273
Net Working Capital (NWC)
0.00 2,467 9,197 5,951 5,208 6,228 5,937 3,517 3,310 4,220
Net Nonoperating Expense (NNE)
534 51 192 152 116 4,576 -680 -30,555 -251 -170
Net Nonoperating Obligations (NNO)
0.00 -704 1,319 3,504 3,373 3,501 2,874 4,169 3,374 2,659
Total Depreciation and Amortization (D&A)
530 550 1,103 1,486 1,418 1,317 1,105 1,061 1,087 1,136
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 13.19% 24.47% 13.86% 9.56% 14.42% 10.36% 8.06% 3.18% 3.27%
Debt-free Net Working Capital to Revenue
0.00% 20.68% 65.39% 30.13% 23.19% 34.37% 29.15% 19.82% 13.56% 15.35%
Net Working Capital to Revenue
0.00% 18.86% 53.54% 26.01% 21.85% 30.08% 28.96% 16.62% 12.98% 15.16%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.34) $0.46 $0.23 ($14.73) ($0.27) ($0.61) $1.93 $3.00
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 1.13B 1.04B 1.03B 1.04B 2.05B 1.01B 1.00B 990.11M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.34) $0.45 $0.23 ($14.73) ($0.27) ($0.61) $1.91 $2.98
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 1.13B 1.04B 1.03B 1.04B 2.05B 1.01B 1.00B 990.11M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($0.34) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 1.13B 1.04B 1.03B 1.04B 2.05B 1.01B 1.00B 990.11M
Normalized Net Operating Profit after Tax (NOPAT)
1,666 520 351 799 991 463 1,105 1,323 1,959 3,116
Normalized NOPAT Margin
9.98% 3.97% 2.04% 3.49% 4.16% 2.23% 5.39% 6.25% 7.68% 11.20%
Pre Tax Income Margin
-0.95% 2.74% -1.95% 2.97% 3.16% -73.42% 2.09% 0.10% 10.41% 11.73%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-0.32 4.51 -1.56 4.05 4.18 -56.58 2.43 1.09 13.29 17.49
NOPAT to Interest Expense
-0.81 2.32 -1.52 1.95 1.63 -42.37 -3.38 -123.54 7.96 14.34
EBIT Less CapEx to Interest Expense
-5.13 0.55 -5.32 1.64 0.06 -59.56 0.62 -1.98 8.59 12.06
NOPAT Less CapEx to Interest Expense
-5.61 -1.65 -5.28 -0.46 -2.49 -45.35 -5.19 -126.61 3.26 8.91
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% -103.84% 286.22% 274.91% -4.72% -226.97% -125.61% 39.90% 27.79%
Augmented Payout Ratio
0.00% 0.00% -225.83% 1,164.66% 367.16% -4.72% -358.48% -268.86% 67.21% 43.88%

Quarterly Metrics And Ratios for Baker Hughes

This table displays calculated financial ratios and metrics derived from Baker Hughes' official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.66% 18.22% 25.12% 23.69% 15.73% 12.28% 13.05% 4.02% 7.76% 0.14% -3.21%
EBITDA Growth
-37.06% 107.01% 395.33% 131.90% 26.66% -11.71% 21.73% 24.72% 35.32% -2.61% 13.95%
EBIT Growth
-47.70% 228.29% 212.94% 286.60% 38.63% -17.23% 29.61% 31.68% 49.21% -4.08% 17.22%
NOPAT Growth
28.50% 180.53% 2,080.42% 3,031.94% 56.37% 40.86% 69.47% 44.73% 77.87% 15.00% 9.46%
Net Income Growth
-44.05% 626.25% 149.46% 5,922.22% 139.89% -20.31% 40.34% 47.71% 163.86% -11.66% 22.38%
EPS Growth
-39.02% 0.00% 147.62% 2,650.00% 72.00% -21.05% 45.00% 50.98% 174.42% -11.11% 22.41%
Operating Cash Flow Growth
16.02% 540.28% 167.60% 35.68% 3.79% 70.07% -59.49% 24.69% 27.68% -9.57% 46.55%
Free Cash Flow Firm Growth
-46.49% 40.75% -95.61% -111.21% -71.73% -38.65% 469.49% 21.40% -50.63% -177.42% -327.74%
Invested Capital Growth
-4.72% -4.25% 1.51% 3.75% 1.06% -1.33% 1.21% 4.57% 4.35% 5.91% 7.67%
Revenue Q/Q Growth
9.98% -3.20% 10.48% 5.16% 2.91% -6.09% 11.23% -3.24% 6.60% -12.72% 7.52%
EBITDA Q/Q Growth
43.10% 64.61% -13.27% 13.50% -21.84% 14.74% 19.59% 16.29% -15.20% -21.18% 46.60%
EBIT Q/Q Growth
95.69% 101.47% -18.45% 20.24% -29.83% 20.28% 27.71% 22.16% -20.49% -27.66% 66.83%
NOPAT Q/Q Growth
2,239.48% -6.91% 3.50% 42.23% 14.10% -16.14% 24.53% 21.46% 40.24% -45.20% 18.96%
Net Income Q/Q Growth
2,188.89% 209.04% -28.74% 26.57% -13.93% 2.66% 25.49% 33.22% 53.75% -65.63% 73.84%
EPS Q/Q Growth
1,350.00% 128.00% -29.82% 27.50% -15.69% -55.00% 28.89% 32.76% 53.25% -66.10% 77.50%
Operating Cash Flow Q/Q Growth
50.42% -48.66% 86.33% -5.70% 15.06% -15.88% -55.61% 190.23% 17.82% -40.42% -28.07%
Free Cash Flow Firm Q/Q Growth
-23.75% -8.00% -94.71% -402.15% 292.24% 99.66% -50.89% -141.70% 220.75% -415.28% -46.85%
Invested Capital Q/Q Growth
2.88% 2.13% 0.04% -1.30% 0.21% -0.29% 2.62% 1.98% -0.01% 1.21% 4.32%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
22.62% 20.10% 20.76% 20.22% 21.19% 19.91% 20.87% 22.32% 20.78% 22.95% 23.37%
EBITDA Margin
11.24% 19.12% 15.01% 16.20% 12.31% 15.04% 16.16% 19.43% 15.45% 13.96% 19.03%
Operating Margin
11.21% 7.66% 8.14% 10.75% 9.53% 10.17% 11.67% 13.46% 9.03% 11.70% 12.84%
EBIT Margin
6.93% 14.42% 10.64% 12.17% 8.30% 10.63% 12.20% 15.40% 11.49% 9.52% 14.78%
Profit (Net Income) Margin
3.18% 10.16% 6.56% 7.89% 6.60% 7.21% 8.14% 11.20% 16.16% 6.36% 10.29%
Tax Burden Percent
54.34% 76.45% 67.43% 69.04% 86.40% 72.23% 70.51% 76.71% 150.44% 72.91% 73.53%
Interest Burden Percent
84.60% 92.23% 91.37% 93.94% 92.06% 93.99% 94.60% 94.83% 93.50% 91.67% 94.71%
Effective Tax Rate
45.66% 23.55% 32.57% 30.96% 13.60% 27.77% 29.49% 23.29% -50.44% 27.09% 26.47%
Return on Invested Capital (ROIC)
6.73% 6.61% 6.75% 9.85% 11.17% 10.16% 11.57% 14.62% 19.59% 12.24% 12.98%
ROIC Less NNEP Spread (ROIC-NNEP)
1.85% 12.98% 8.53% 10.71% 8.21% 9.93% 11.40% 16.39% 25.87% 7.63% 14.78%
Return on Net Nonoperating Assets (RNNOA)
0.42% 3.21% 2.13% 2.61% 2.06% 2.46% 2.74% 3.53% 4.79% 1.41% 2.88%
Return on Equity (ROE)
7.14% 9.82% 8.87% 12.47% 13.23% 12.61% 14.32% 18.15% 24.38% 13.65% 15.87%
Cash Return on Invested Capital (CROIC)
-157.68% 3.45% 4.76% 4.98% 8.09% 11.09% 9.71% 7.58% 10.45% 9.43% 7.45%
Operating Return on Assets (OROA)
4.22% 9.07% 7.10% 8.58% 5.95% 7.72% 9.07% 11.35% 8.49% 7.05% 10.82%
Return on Assets (ROA)
1.94% 6.40% 4.37% 5.56% 4.73% 5.24% 6.05% 8.26% 11.94% 4.71% 7.54%
Return on Common Equity (ROCE)
6.68% 9.55% 8.77% 12.31% 13.11% 12.49% 14.18% 17.98% 24.14% 13.51% 15.72%
Return on Equity Simple (ROE_SIMPLE)
0.00% -0.52% 7.76% 11.19% 0.00% 12.03% 12.96% 14.02% 0.00% 17.33% 17.43%
Net Operating Profit after Tax (NOPAT)
360 335 347 493 562 472 587 713 1,000 548 652
NOPAT Margin
6.09% 5.86% 5.49% 7.42% 8.23% 7.35% 8.23% 10.33% 13.59% 8.53% 9.44%
Net Nonoperating Expense Percent (NNEP)
4.88% -6.36% -1.78% -0.86% 2.96% 0.23% 0.17% -1.77% -6.28% 4.61% -1.79%
Return On Investment Capital (ROIC_SIMPLE)
1.70% - - - 2.61% - - - 4.34% 2.36% 2.73%
Cost of Revenue to Revenue
77.38% 79.90% 79.24% 79.78% 78.81% 80.09% 79.13% 77.68% 79.22% 77.05% 76.63%
SG&A Expenses to Revenue
10.92% 11.46% 11.01% 9.44% 9.28% 9.63% 9.01% 8.86% 7.94% 8.98% 8.21%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.27% 2.33%
Operating Expenses to Revenue
11.41% 12.44% 12.62% 9.47% 11.66% 9.74% 9.20% 8.86% 11.75% 11.25% 10.54%
Earnings before Interest and Taxes (EBIT)
409 824 672 808 567 682 871 1,064 846 612 1,021
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
664 1,093 948 1,076 841 965 1,154 1,342 1,138 897 1,315
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.97 1.93 2.06 2.28 2.18 2.19 2.25 2.22 2.40 2.55 2.15
Price to Tangible Book Value (P/TBV)
6.61 6.09 6.33 6.82 6.53 6.46 6.44 5.96 5.91 6.23 4.76
Price to Revenue (P/Rev)
1.34 1.29 1.34 1.41 1.31 1.29 1.30 1.32 1.46 1.56 1.38
Price to Earnings (P/E)
0.00 0.00 27.09 20.60 17.26 18.50 17.63 16.04 13.63 14.87 12.46
Dividend Yield
2.60% 2.63% 2.43% 2.24% 2.34% 2.39% 2.87% 2.30% 2.05% 1.96% 2.30%
Earnings Yield
0.00% 0.00% 3.69% 4.85% 5.80% 5.41% 5.67% 6.23% 7.34% 6.72% 8.02%
Enterprise Value to Invested Capital (EV/IC)
1.75 1.72 1.84 2.03 1.96 1.97 2.01 2.00 2.20 2.33 1.97
Enterprise Value to Revenue (EV/Rev)
1.54 1.49 1.51 1.56 1.45 1.42 1.44 1.44 1.56 1.67 1.49
Enterprise Value to EBITDA (EV/EBITDA)
24.45 17.28 11.10 10.15 9.36 9.70 9.63 9.17 9.44 10.15 8.68
Enterprise Value to EBIT (EV/EBIT)
119.11 38.76 16.64 14.14 12.91 13.62 13.27 12.39 12.54 13.51 11.46
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 29.67 23.93 21.55 20.09 18.54 16.98 15.29 15.78 13.80
Enterprise Value to Operating Cash Flow (EV/OCF)
17.29 14.42 12.50 12.67 12.10 10.98 13.52 12.83 13.03 14.25 12.02
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 48.71 39.01 41.65 24.37 17.67 20.83 27.00 21.52 25.39 27.47
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.46 0.45 0.44 0.43 0.39 0.39 0.38 0.37 0.35 0.35 0.34
Long-Term Debt to Equity
0.41 0.40 0.38 0.38 0.38 0.38 0.37 0.37 0.35 0.35 0.33
Financial Leverage
0.23 0.25 0.25 0.24 0.25 0.25 0.24 0.22 0.19 0.18 0.20
Leverage Ratio
2.22 2.24 2.30 2.34 2.37 2.37 2.35 2.33 2.31 2.30 2.24
Compound Leverage Factor
1.88 2.06 2.10 2.20 2.18 2.23 2.22 2.21 2.16 2.11 2.13
Debt to Total Capital
31.43% 30.96% 30.33% 30.19% 27.95% 27.86% 27.27% 26.97% 26.10% 25.93% 25.24%
Short-Term Debt to Total Capital
3.20% 3.18% 3.64% 3.64% 0.69% 0.68% 0.16% 0.23% 0.23% 0.24% 0.28%
Long-Term Debt to Total Capital
28.23% 27.78% 26.69% 26.56% 27.26% 27.18% 27.11% 26.74% 25.87% 25.70% 24.97%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.62% 0.63% 0.63% 0.66% 0.70% 0.74% 0.68% 0.69% 0.69% 0.71% 0.72%
Common Equity to Total Capital
67.95% 68.41% 69.05% 69.15% 71.35% 71.40% 72.05% 72.34% 73.21% 73.36% 74.04%
Debt to EBITDA
4.99 3.50 2.10 1.76 1.52 1.57 1.46 1.40 1.31 1.32 1.27
Net Debt to EBITDA
3.12 2.23 1.21 0.91 0.85 0.86 0.89 0.78 0.58 0.60 0.62
Long-Term Debt to EBITDA
4.48 3.14 1.85 1.55 1.48 1.53 1.45 1.39 1.30 1.30 1.26
Debt to NOPAT
-0.21 -38.29 5.60 4.15 3.50 3.25 2.81 2.60 2.12 2.05 2.03
Net Debt to NOPAT
-0.13 -24.40 3.24 2.16 1.96 1.78 1.72 1.45 0.94 0.93 0.99
Long-Term Debt to NOPAT
-0.19 -34.35 4.93 3.65 3.42 3.17 2.80 2.58 2.10 2.03 2.00
Altman Z-Score
1.21 1.27 1.34 1.49 1.45 1.49 1.63 1.70 1.86 1.97 1.88
Noncontrolling Interest Sharing Ratio
6.55% 2.81% 1.12% 1.24% 0.94% 0.97% 0.92% 0.94% 0.95% 0.99% 0.95%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.32 1.32 1.28 1.27 1.25 1.25 1.27 1.30 1.32 1.34 1.41
Quick Ratio
0.76 0.75 0.75 0.77 0.75 0.73 0.74 0.75 0.81 0.79 0.77
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,286 1,183 63 -189 363 726 356 -149 179 -566 -831
Operating Cash Flow to CapEx
372.61% 174.62% 363.98% 371.56% 312.75% 278.01% 143.80% 394.53% 403.39% 278.04% 187.50%
Free Cash Flow to Firm to Interest Expense
20.41 18.48 1.08 -3.86 8.08 17.70 7.58 -2.70 3.26 -11.09 -15.39
Operating Cash Flow to Interest Expense
14.25 7.20 14.81 16.53 20.71 19.12 7.40 18.36 21.64 13.90 9.44
Operating Cash Flow Less CapEx to Interest Expense
10.43 3.08 10.74 12.08 14.09 12.24 2.26 13.71 16.27 8.90 4.41
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.61 0.63 0.67 0.71 0.72 0.73 0.74 0.74 0.74 0.74 0.73
Accounts Receivable Turnover
3.64 3.66 3.89 4.07 3.91 3.98 4.01 4.07 3.92 4.10 4.07
Inventory Turnover
3.91 3.91 4.08 4.28 4.18 4.11 4.26 4.22 4.38 4.18 4.26
Fixed Asset Turnover
4.49 4.73 5.04 5.37 5.41 5.55 5.59 5.50 5.55 5.51 5.45
Accounts Payable Turnover
4.17 4.35 4.64 4.91 4.62 4.70 4.88 5.04 4.88 4.85 4.84
Days Sales Outstanding (DSO)
100.14 99.62 93.89 89.76 93.25 91.67 90.93 89.75 93.10 89.05 89.65
Days Inventory Outstanding (DIO)
93.30 93.42 89.43 85.20 87.23 88.72 85.70 86.57 83.39 87.24 85.78
Days Payable Outstanding (DPO)
87.60 83.82 78.60 74.39 79.01 77.62 74.82 72.47 74.80 75.28 75.37
Cash Conversion Cycle (CCC)
105.84 109.23 104.72 100.58 101.47 102.77 101.81 103.85 101.69 101.01 100.06
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
18,694 19,093 19,101 18,853 18,893 18,839 19,332 19,715 19,714 19,953 20,815
Invested Capital Turnover
1.10 1.13 1.23 1.33 1.36 1.38 1.41 1.42 1.44 1.44 1.38
Increase / (Decrease) in Invested Capital
-926 -848 284 682 199 -254 231 862 821 1,114 1,483
Enterprise Value (EV)
32,636 32,832 35,182 38,363 37,052 37,157 38,858 39,438 43,409 46,426 41,103
Market Capitalization
28,336 28,453 31,206 34,760 33,527 33,709 35,100 35,912 40,590 43,515 37,985
Book Value per Share
$14.27 $14.55 $14.94 $15.10 $15.27 $15.42 $15.61 $16.30 $17.07 $17.21 $17.86
Tangible Book Value per Share
$4.25 $4.62 $4.87 $5.05 $5.11 $5.23 $5.46 $6.07 $6.94 $7.06 $8.05
Total Capital
21,182 21,508 21,906 22,054 21,539 21,556 21,616 22,379 23,078 23,230 23,902
Total Debt
6,657 6,659 6,644 6,659 6,020 6,006 5,895 6,036 6,023 6,024 6,034
Total Long-Term Debt
5,980 5,975 5,847 5,857 5,872 5,859 5,861 5,984 5,970 5,969 5,968
Net Debt
4,169 4,244 3,839 3,458 3,374 3,289 3,611 3,372 2,659 2,747 2,947
Capital Expenditures (CapEx)
241 264 236 218 298 282 242 256 295 255 272
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,706 2,037 1,487 1,081 812 671 1,094 1,166 909 1,025 2,082
Debt-free Net Working Capital (DFNWC)
4,194 4,452 4,292 4,282 3,458 3,388 3,378 3,830 4,273 4,302 5,169
Net Working Capital (NWC)
3,517 3,768 3,495 3,480 3,310 3,241 3,344 3,778 4,220 4,247 5,103
Net Nonoperating Expense (NNE)
172 -246 -67 -31 111 8.67 6.35 -61 -190 139 -59
Net Nonoperating Obligations (NNO)
4,169 4,244 3,839 3,458 3,374 3,289 3,611 3,372 2,659 2,747 2,947
Total Depreciation and Amortization (D&A)
255 269 276 268 274 283 283 278 292 285 294
Debt-free, Cash-free Net Working Capital to Revenue
8.06% 9.24% 6.38% 4.40% 3.18% 2.56% 4.05% 4.27% 3.27% 3.68% 7.54%
Debt-free Net Working Capital to Revenue
19.82% 20.20% 18.42% 17.42% 13.56% 12.93% 12.50% 14.03% 15.35% 15.45% 18.72%
Net Working Capital to Revenue
16.62% 17.10% 15.00% 14.16% 12.98% 12.37% 12.37% 13.84% 15.16% 15.26% 18.48%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.25 $0.00 $0.41 $0.51 $0.44 $0.46 $0.58 $0.77 $1.19 $0.41 $0.71
Adjusted Weighted Average Basic Shares Outstanding
1.01B 1.01B 1.01B 1.01B 1.00B 998.00M 993.42M 989.53M 990.11M 990.75M 985.88M
Adjusted Diluted Earnings per Share
$0.25 $0.00 $0.40 $0.51 $0.43 $0.45 $0.58 $0.77 $1.18 $0.40 $0.71
Adjusted Weighted Average Diluted Shares Outstanding
1.01B 1.01B 1.01B 1.01B 1.00B 998.00M 993.42M 989.53M 990.11M 990.75M 985.88M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.01B 1.01B 1.01B 1.01B 1.00B 998.00M 993.42M 989.53M 990.11M 990.75M 985.88M
Normalized Net Operating Profit after Tax (NOPAT)
360 378 415 494 703 477 597 713 662 548 652
Normalized NOPAT Margin
6.09% 6.61% 6.58% 7.44% 10.29% 7.43% 8.37% 10.33% 8.98% 8.53% 9.44%
Pre Tax Income Margin
5.86% 13.30% 9.72% 11.43% 7.64% 9.99% 11.54% 14.61% 10.74% 8.73% 13.99%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
6.49 12.88 11.59 16.49 12.60 16.63 18.53 19.35 15.38 12.00 18.91
NOPAT to Interest Expense
5.71 5.23 5.98 10.06 12.50 11.50 12.50 12.97 18.19 10.75 12.08
EBIT Less CapEx to Interest Expense
2.67 8.75 7.52 12.04 5.98 9.76 13.38 14.69 10.02 7.00 13.87
NOPAT Less CapEx to Interest Expense
1.88 1.11 1.91 5.61 5.88 4.63 7.35 8.32 12.83 5.75 7.04
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-125.61% -974.03% 65.84% 46.46% 39.90% 43.41% 40.66% 36.49% 27.79% 28.94% 28.31%
Augmented Payout Ratio
-268.86% -1,742.86% 105.45% 65.20% 67.21% 80.99% 78.45% 71.53% 43.88% 46.34% 45.95%

Key Financial Trends

Over the past four years, Baker Hughes (NASDAQ: BKR) has demonstrated consistent growth and improving financial health across its income statement, balance sheet, and cash flow metrics.

Income Statement Trends:

  • Total revenue steadily increased from $5.72 billion in Q1 2023 to $6.91 billion in Q2 2025, indicating robust top-line growth.
  • Net income attributable to common shareholders rose from $455 million in Q1 2023 to $701 million in Q2 2025, reflecting improving profitability.
  • Basic EPS increased from $0.46 in Q1 2023 to $0.71 in Q2 2025, benefiting shareholders.
  • Operating expenses have been relatively stable, fluctuating between $700 million and $860 million quarterly, suggesting consistent cost management.
  • Impairment charges appeared sporadically, such as $280 million in Q4 2024, which weighed on operating income in those periods.
  • Interest expense remains consistent around $50-60 million quarterly, indicating stable debt costs.

Balance Sheet Highlights:

  • Total assets grew from approximately $35 billion in Q1 2023 to $38.7 billion by Q2 2025, supporting business expansion.
  • Cash and equivalents increased from about $2.42 billion in Q1 2023 to $3.09 billion in Q2 2025, improving liquidity.
  • Total current liabilities remained roughly steady near $12.5 billion, indicating stable short-term obligations.
  • Long-term debt stayed around $5.85 to $6 billion, showing consistent leverage levels without significant increase.
  • Retained earnings remain negative through the period, although the negative balance is decreasing from about -$10.2 billion in Q1 2023 to -$4.7 billion in Q2 2025, implying accumulated losses still on the books.

Cash Flow Statement Observations:

  • Net cash from operating activities improved from $461 million in Q1 2023 to $510 million in Q2 2025, supporting operational strength.
  • Significant cash outflows in financing activities, mainly due to repurchase of common equity (about $196 million in Q2 2025) and dividends paid (~$227 million in Q2 2025), which could pressure cash reserves.
  • Investing activities show consistent cash outflows for property, plant and equipment purchases (around $300 million quarterly), indicating ongoing capital expenditures which could stress cash flow.
  • Cash interest paid is stable around $48-98 million quarterly, reflecting consistent financing costs.

Summary:

Baker Hughes has shown a positive trend of revenue growth and improving net income over the last four years with increased cash reserves and asset base supporting its operations. The company maintains stable debt levels and operating expenses. However, the presence of impairment charges in some quarters and continued negative retained earnings highlight some underlying challenges. Furthermore, sizable cash outflows for dividends and equity repurchases affect liquidity, which investors should monitor. Overall, Baker Hughes appears on a growth trajectory with cautious capital return policies.

08/25/25 06:13 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Baker Hughes' Financials

When does Baker Hughes' financial year end?

According to the most recent income statement we have on file, Baker Hughes' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Baker Hughes' net income changed over the last 9 years?

Baker Hughes' net income appears to be on a downward trend, with a most recent value of $3.01 billion in 2024, falling from -$631 million in 2015. The previous period was $1.97 billion in 2023. See where experts think Baker Hughes is headed by visiting Baker Hughes' forecast page.

What is Baker Hughes' operating income?
Baker Hughes' total operating income in 2024 was $3.08 billion, based on the following breakdown:
  • Total Gross Profit: $5.84 billion
  • Total Operating Expenses: $2.76 billion
How has Baker Hughes' revenue changed over the last 9 years?

Over the last 9 years, Baker Hughes' total revenue changed from $16.69 billion in 2015 to $27.83 billion in 2024, a change of 66.8%.

How much debt does Baker Hughes have?

Baker Hughes' total liabilities were at $21.31 billion at the end of 2024, a 0.6% decrease from 2023, and a 210.3% increase since 2016.

How much cash does Baker Hughes have?

In the past 8 years, Baker Hughes' cash and equivalents has ranged from $0.00 in 2017 to $4.13 billion in 2020, and is currently $3.36 billion as of their latest financial filing in 2024.

How has Baker Hughes' book value per share changed over the last 9 years?

Over the last 9 years, Baker Hughes' book value per share changed from 0.00 in 2015 to 17.07 in 2024, a change of 1,707.4%.



This page (NASDAQ:BKR) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners